Source: Annual Congress 2007 - COPD, sarcoidosis, idiopathic pulmonary fibrosis, cystic fibrosis, gastro-oesophageal reflux and cough variant asthma - pathogenesis and differential diagnosis
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Stepanisheva, G. Ignatova, N. Gasyuk, E. Nikolaeva, N. Sadrutdinova (Chelyabinsk, Russian Federation). Nitric oxide in COPD patients saliva as marker of oxidative stress. Eur Respir J 2007; 30: Suppl. 51, 2228

Member's Comments

No comment yet.

Related content which might interest you: Oxidative stress and products of nitric oxide metabolism in COPD and in smokers Source: Eur Respir J 2001; 18: Suppl. 33, 273s Year: 2001 Cytokine status and nitrosative stress indicators in patients with an exacerbation of COPD Source: International Congress 2015 – Translational research in respiratory care: new findings Year: 2015 The cycle of the nitric oxide metabolism in patients with COPD and chronic cerebrovascular diseases (CCVD) Source: Annual Congress 2013 –The vulnerable patient and ageing cells Year: 2013 Base nitric oxide level in saliva in patients with COPD Source: Eur Respir J 2005; 26: Suppl. 49, 736s Year: 2005 Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Exhaled nitric oxide (NO) in patients with chronic cough Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 Bronchial and alveolar nitric oxide levels in healthy volunteers and patients with severe asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Exhaled nitric oxide as a biomarker in different COPD phenotypes Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Nitric oxide/oxidative stress Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Elevated levels of alveolar nitric oxide in patients with inflammatory bowel disease Source: International Congress 2016 – Airway biomarkers Year: 2016 Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model Source: Eur Respir J 2006; 28: 1236-1244 Year: 2006 Biomarkers of oxidative stress in chronic respiratory diseases Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Decreased haem oxygenase-1 and increased inducible nitric oxide synthase in the lung of severe COPD patients Source: Eur Respir J 2003; 21: 971-976 Year: 2003 Nitric oxide oxidation products in bronchoalveolar lavage of patients with different severity of asthma Source: Annual Congress 2013 –Asthma Year: 2013 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Airway and systemic nitric oxide pathway in COPD Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019